Production of reactive oxygen intermediates following CD40 ligation correlates with c-Jun N-terminal kinase activation and IL-6 secretion in murine B lymphocytes

European Journal of Immunology

Volumn 28, Issue 12, 1998, Pages 4188-4197

  Lee, Jong Ran ^a   Koretzky, Gary A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

c Jun N terminal kinase; CD40; IL 6; NF B; Reactive oxygen intermediate

Indexed keywords

ACETYLCYSTEINE; GLYCOPROTEIN GP 39; INTERLEUKIN 6; LUCIFERASE; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CELL SECRETION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; ONCOGENE C JUN; PLASMID; PRIORITY JOURNAL; SECOND MESSENGER; SIGNAL TRANSDUCTION; SPLEEN CELL;

EID: 0031739197     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199812)28:12<4188::AID-IMMU4188>3.0.CO;2-B     Document Type: Article

References (50)

1. Foy, T. M., Aruffo, A., Bajorath, J., Buhlmann, J. E. and Noelle, R. J., Immune regulation by CD40 and its ligand GP39. Annu. Rev. Immunol. 1996. 14: 591-617.
2. Banchereau, J., Bazan, R, Blanchard, D., Briere, F., Galizzi, J. P., vanKooten, C., Liu, Y. J., Rousset, F. and Saeland, S., The CD40 antigen and its ligand. Annu. Rev. Immunol. 1994. 12: 881-922.
3. Clark, E. A. and Ledbetter, J. A., How B and T cells talk to each other. Nature 1994. 367: 425-428.
4. Klaus, S. J., Berberich, L, Shu, G. and Clark, E. A., CD40 and its ligand in the regulation of humoral immunity. Semin, Immunol. 1994. 6: 279-286.
5. Hostager, B. S., Hsing, Y., Harms, D. E. and Bishop, G. A., Different CD40-mediated signaling events require distinct CD40 structural features. J. Immunol. 1996. 157: 1047-1053.
6. Lipsky, P. E., Attrep, J. F., Grammer, A. C., Mcllraith, M. J. and Nishioka, Y., Analysis of CD40-CD40 ligand interactions in the regulation of human B cell function. Ann. N. Y. Acad. Sci. 1997. 815: 372-383.
7. Hsing, Y., Hostager, B. S. and Bishop, G. A., Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes. J. Immunol. 1997. 159: 4898-4906.
8. Uckun, F. M., Schieven, G. L., Dibirdik, I., Chandan-Langlie, M., Tuel-Ahlgren, L. and Ledbetter, J. A., Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny. J. Biol. Chem. 1991. 266: 17478-17485.
9. Faris, M., Gaskin, F., Parson, T. and Fu, S. M., CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein. J. Exp. Med. 1994. 179: 1923-1931.
10. Ren, C. L., Morio, T., Fu, S. M. and Geha, R. S., Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase Cγ2. J. Exp. Med. 1994. 179: 673-680.
11. Sakata, N., Patel, H, R., Terada, N., Aruffo, A., Johnson, G. L. and Gelfand, E. W., Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B cells. J. Biol. Chem. 1995. 270: 30823-30828.
12. Berberich, I., Shu, G., Siebelt, F., Woodgett, J. R., Kyriakis, J. M. and Clark, E. A., Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases. EMBO J. 1996. 15: 92-101.
13. Li, Y.-Y., Baccam, M., Waters, S. B., Pessin, J. E., Bishop, G. A. and Koretzky, G. A., CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells. J. Immunol. 1996. 157: 1440-1447.
14. Purkerson, J. M. and Parker, D. C., Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway. J. Immunol. 1998. 160: 2121-2129.
15. 2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B Cell Line. J. Immunol. 1998. 161: 1637-1644.
16. Davis, R. J., MAPKs: new JNK expands the group. Trends Biochem. Sci. 1994. 19: 470-473.
17. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J. and Woodgett, J. R., The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994. 369: 156-160.
18. Su, B. and Karin, M., Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol. 1996. 8: 402-411.
19. Lo, Y. Y. C. and Cruz, T. F., Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J. Biol. Chem. 1995. 270: 11727-11730.
20. Kohno, T., Yamada, Y., Hata, T., Mori, H., Yamamura, M., Tomonaga, M., Urata, Y., Goto, S. and Kondo, T., Relation of oxidative stress and glutathione synthesis to CD95 (Fas/Apo-1)-mediated apoptosis of adult T cell leukemia cells. J. Immunol. 1996. 156: 4722-4728.
21. 2-terminal kinases. J. Biol. Chem. 1996. 271: 15703-15707.
22. Schreck, R., Rieber, P. and Baeuerle, P. A., Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991. 10: 2247-2258.
23. Berberich, I., Shu, G. L. and Clark, E. A., Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J. Immunol. 1994. 153: 4357-4366.
24. Miyamoto, S., Seufzer, B. J. and Shumway, S. D., Novel I(greek small letter script kappa)Bα proteolytic pathway in WEHI 231 immature B cells. Mol. Cell. Biol. 1998. 18: 19-29.
25. Francis, D. A., Karras, J. G., Ke, X. Y., Sen, R. and Rothstein, T. L., Induction of the transcription factors NF-kappa B, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol. 1995. 7: 151-161.
26. Shibanuma, M., Kuroki, T. and Nose, K., Inhibition by N-acetyl-L-cysteine of interleukin-6 mRNA induction and activation of NF kappa B by tumor necrosis factor alpha in a mouse fibroblastic cell line, BALB/3T3. FEBS Lett. 1994. 353: 62-66.
27. Munoz, C., Pascual-Salcedo, D., Castellanos, M. C., Alfranca, A., Aragones, J., Vara, A., Redondo, M. J. and de Landazuri, M. O., Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-kappa B and AP-1 transcription factors activity. Blood 1996. 88: 3482-3490.
28. Peristeris, P., Clark, B. D., Gatti, S., Faggioni, R., Mantovani, A., Mengozzi, M., Orencole, S. F., Sironi, M. and Ghezzi, P., N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell. Immunol. 1992. 140: 390-399.
29. Allen, R. C., Armitage, R. J., Conley, M. E., Rosenblatt, H., Jenkins, N. A., Copeland, N. G., Bedell, M. A., Edelhoff, S., Disteche, C. M., Simoneaux, D. K., Fanslow, W. C., Belmont, J. and Spriggs, M. K., CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993. 259: 990-993.
30. Korthauer, U., Graf, D., Mages, H. W., Briere, F., Padayachee, M., Malcolm, S., Ugazio, A. G., Notarangelo, L. D., Levinsky, R. J. and Kroczek, R. A., Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 1993. 361: 539-541.
31. Aruff, A., Hollenbaugh, D., Wu, L. H. and Ochs, H. D., The molecular basis of X-linked agammaglobulinemia, hyper-IgM syndrome, and severe combined immunodeficiency in humans. Curr. Opin. Hematol. 1994. 1: 12-18.
32. Lenardo, M. J. and Baltimore, D., NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989. 58: 227-229.
33. Liou, H. C. and Baltimore, D., Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. Curr. Opin. Cell Biol. 1993. 5: 477-487.
34. Halliwell, B. and Gutteridge, J. M. C., Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990. 186: 1-85.
35. Cotgreave, I. A., Moldeus, P. and Orrenius, S., Host biochemical defense mechanisms against prooxidants. Annu. Rev. Pharmacol. Toxicol. 1988. 28: 189-212.
36. Suzuki, Y. J., Mizuno, M. and Packer, L., Signal transduction for nuclear factor-(greek small letter script kappa)B activation. Proposed location of antioxidant-inhibitable step. J. Immunol. 1994. 153: 5008-5015.
37. Winrow, V. R., Winyard, P. G., Morris, C. J. and Blake, D. R., Free radicals in inflammation: second messengers and mediators of tissue destruction. Br. Med. Bull. 1993. 49: 506-522.
38. Schulze-Osthoff, K., Los, M. and Baeuerle, P. A., Redox signalling by transcription factors NF-(greek small letter script kappa)B and AP-1 in lymphocytes. Biochem. Pharmacol. 1995. 50: 735-741.
39. Los, M., Schenk, H., Hexel, K., Baeuerle, P. A., Droge, W. and Schulze-Osthoff, K., IL-2 gene expression and NF-(greek small letter script kappa)B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 1995. 14: 3731-3740.
40. Sulciner, D. J., Irani, K., Yu, Z. X., Ferrans, V. J., Goldschmidt-Clermont, P. and Finkel, T., rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-(greek small letter script kappa)B activation. Mol. Cell. Biol. 1996. 16: 7115-7121.
41. Schulze-Osthoff, K., Beyaert, R., Vandevoorde, V., Haegeman, G. and Fiers, W., Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 1993. 12: 3095-3104.
42. Beyaert, R., Cuenda, A., Berghe, W. V., Plaisance, S., Lee, J. C., Haegeman, G., Cohen, P. and Fiers, W., The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 1996. 15: 1914-1923.
43. Oberley, L. W., McCormick, M. L., Sierra-Rivera, E. and St. Clair, D. K., Manganese Superoxide dismutase in normal and transformed human embryonic lung fibroblasts. Free Rad. Biol. Med. 1989. 6: 379-384.
44. Bishop, G. A., Ramirez, L. M. and Waldschmidt, T. J., Differential responses to Ig and class II-mediated signals in splenic B cell subsets from normal and autoimmune mice. Int. Immunol. 1994. 6: 1049-1059.
45. Waldschmidt, T. J., Kroese, F. G. M., Tygrett, L. T., Conrad, D. H. and Lynch, R. G., The expression of B cell surface receptors. III. The murine low-affinity IgE Fc receptor is not expressed on Ly1 or 'Ly1-like' B cells. Int. Immunol. 1991. 3: 305-315.
46. Bass, D. A., Parce, J. W., Dechatelet, L. R., Szejda, P., Seeds, M. C. and Thomas, M., Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 1983. 130: 1910-1918.
47. Hockenbery, D. M., Oltvai, Z. N., Yin, X.-M., Milliman, C. L. and Korsmeyer, S. J., Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993. 75: 241-251.
48. Latinis, K. M. and Koretzky, G. A., Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells. Blood 1996. 87: 871-875.
49. van den Hoff, M. J. B., Moorman, A. F. M. and Lamers, W. H., Electroporation in 'intracellular' buffer increases cell survival. Nucleic Acids Res. 1992. 20: 2902.
50. Spitz, D. R. and Oberley, L. W., An assay for Superoxide dismutase activity in mammalian tissue homogenates. Anal. Biochem. 1989. 179: 8-18.